Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
02/2007
02/14/2007CN1912093A Holly tonic wine
02/14/2007CN1911954A Glycyrrhizic acid derivative having amino acid, its preparation method and medicinal composition containing them
02/14/2007CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
02/14/2007CN1911930A Chemokine receptor anagonists, methods and use therefor
02/14/2007CN1911927A Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf alpha levels
02/14/2007CN1911438A 血管新生诱导剂 Angiogenic inducer
02/14/2007CN1911427A Medicine for treating chronic diarrhoea
02/14/2007CN1911424A Decoction for treating deficiency of liver-yin and kidney-yin type early hepatocirrhosis, and its prepn. method
02/14/2007CN1911421A Fat-regulating and liver-tonifying type medicine for treating adiposis hepatica
02/14/2007CN1911417A Traditional Chinese medicine prescription for removing tragomaschalia and its prepn. method
02/14/2007CN1911416A Traditional Chinese medicine-Changshu Zhixie prepn. for treating intestine disease and antidiarrheal, and its prepn. method
02/14/2007CN1911402A Medicated liquid for male to health-preserving and prolonging life
02/14/2007CN1911400A Compound poria cocos prepn., and its prepn. method
02/14/2007CN1911355A Medicine composition for treating diarrhea
02/14/2007CN1911354A Medicated liquid for female health preserving and prolonging life
02/14/2007CN1911335A Traditional Chinese medicine composition for treating dyspepsia
02/14/2007CN1911314A Plant extractive and its prepn. method
02/14/2007CN1911308A Medicine for treating infantile anorexia, and its prepn. method
02/14/2007CN1911307A Medicine for treating postoperative gastroenteropathy
02/14/2007CN1911304A Traditional Chinese medicine composition for treating liver diseases and muscle disease
02/14/2007CN1911301A Compound medicine for treating acute/chronic gastroenteritis, and its prepn. method
02/14/2007CN1911300A Compound traditional Chinese medicine prepn. for treating chronic reactivation hepatitis B and its prepn. method
02/14/2007CN1911298A Traditional Chinese medicine decoction for treating deficiency of vital energy type hepatocirrhosis hydroperitoneu, and its prepn. method
02/14/2007CN1911285A Medicine for treating adiposis hepatica, and its prepn. method
02/14/2007CN1911269A Soft capsule of Rabdosia rubescens, and its prepn. method
02/14/2007CN1911268A External dressing type medicine for treating chronic diarrhea, and its prepn. method
02/14/2007CN1911254A Antibiotic peptide cordyceps sinensis extract
02/14/2007CN1911249A Soft capsule of bee glue, and its prodn. art
02/14/2007CN1911248A Mucus medicine of combined western medicine with traditional Chinese medicine for treating stomach trouble
02/14/2007CN1911240A Use of montmorillonite as ingredient for protecting gastrointestinal mucosa before drinking wine
02/14/2007CN1911237A Beta - l-2'-deoxy-nucleosides for the treatment of hepatitis b
02/14/2007CN1911235A Colon target prepn. contg. 5-aminosalicylic acid, and its prepn. method
02/14/2007CN1911233A Medicine composite contg. Moxabilli and antioxidant
02/14/2007CN1911217A Oral disintegration tablets of Bingpazhe germanium for treating chronic hepatitis and its making method
02/14/2007CN1911210A Dispersing tablets of nizatidine, and its prepn. method
02/14/2007CN1911208A Injection of Jiabei mesylate and its prpen. method
02/14/2007CN1300312C Structure and use of anti-hypatitis B virus antisense oligonucleotide of target de-sialoglycoprotein receptor
02/14/2007CN1300293C Process for preparing hygienic medicated wine
02/14/2007CN1300175C Medicinal polysaccharide component of spinulate hedgehog fungus, its prepn and medicinal composition comprising same as active component
02/14/2007CN1300173C Human antibodies that bind huma TNF 'alpha'
02/14/2007CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
02/14/2007CN1300130C Rosa banksiae general lactone extract and its preparing process and application
02/14/2007CN1300114C Phenylpyridine carbonyl piperazine derivative
02/14/2007CN1299771C Colorstrum-based composition
02/14/2007CN1299766C Use of TGF-beta and growth factor in treatment and prevention of intestinal mucosa diseases
02/14/2007CN1299763C Method for preparing anti-hepatitis-B humanbody placenta transfer factor powder injecta
02/14/2007CN1299756C Stomach-benefiting medicine and its prepn
02/14/2007CN1299755C Cinnamon compound medicine, and its preparing method and use
02/14/2007CN1299739C Chinese medicine preparation for treating chronic erosive gastritis and enteritis and preparing method
02/14/2007CN1299734C Composition of traditional Chinese medicine for large intestine hygropyretic disease and its preparation method
02/14/2007CN1299733C Chinese medicine and its preparing method and use
02/14/2007CN1299732C Chinese medicine preparation for treating fatty liver
02/14/2007CN1299730C Chinese medicine wine and preparing method
02/14/2007CN1299727C Chinese medicinal preparation for hepatitis and its preparing method
02/14/2007CN1299725C Pharmaceutical composition for treating viral hepatitis type B and preparation technique thereof
02/14/2007CN1299724C Health care products of lucid ganoderma
02/14/2007CN1299701C Mongolian medicinal and edible powder for treating infants diarrhea and andropathy
02/14/2007CN1299694C Flavone composition for sobering and liver protection and its use
02/14/2007CN1299689C Application of alendronate in preparation of drug for inhibitting bone resorption
02/14/2007CN1299683C Celecoxib compositions
02/14/2007CN1299678C Sulpride dispersion tablets prepn. method
02/14/2007CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
02/14/2007CN1299672C Extracts from sophora,production method and purposes thereof
02/13/2007US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors
02/13/2007US7176219 Salts of quinuclidine derivative
02/13/2007US7176217 such as N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl]-2-azabicyclo[2.2.1]heptane-3-carboxamide, used in cosmetics or drugs as gelatinase inhibitors, for preventing skin aging or wrinkling; preventing diseases due to abnormal metabolism of tissue matrices such as arthritis, ulcers, metastasis or tumors
02/13/2007US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives
02/13/2007US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases
02/13/2007US7175859 aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor
02/13/2007US7175850 Formulation for topical non-invasive application in vivo
02/13/2007US7175849 Polypeptide for use in the treatment of viral disorders
02/13/2007US7175833 Glass composition
02/08/2007WO2007016390A1 Matrix metalloproteinase inhibitors for treating fatty liver disease
02/08/2007WO2007015585A1 Agent for reduction of oxidized albumin level
02/08/2007WO2007014872A1 Combination of itriglumide and proton pump inhibitors in the treatment of gastrointestinal and related disorders
02/08/2007WO2006129318A3 Benzofuran derivatives with therapeutic activities
02/08/2007WO2006127899A3 (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use
02/08/2007WO2006127898A3 (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use
02/08/2007WO2006101244A3 Method and composition for treating mucosal disorders
02/08/2007WO2006063837A3 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
02/08/2007US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc.
02/08/2007US20070032642 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance
02/08/2007US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
02/08/2007US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia
02/08/2007US20070032518 Compounds and methods of use
02/08/2007US20070032497 Fused-ring compounds and use thereof as drugs
02/08/2007US20070032476 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
02/08/2007US20070032433 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
02/08/2007US20070032426 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
02/08/2007US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
02/08/2007US20070031904 Mammalian IAP gene family, primers, probes and detection methods
02/08/2007US20070031903 Mammalian IAP gene family, primers, probes and detection methods
02/08/2007US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1
02/08/2007US20070031511 Method of treatment
02/08/2007US20070031497 Gastric acid secretion inhibiting composition
02/08/2007US20070031441 Immunotherapy based on dendritic cells
02/08/2007US20070031375 IL-16 antagonist peptides and DNA encoding the peptides
02/08/2007DE202006001770U1 Use of activated carbon particles, preferably in the form of granules and pellets, for the production of medicaments for treating inflammatory diseases of stomach/intestinal tract diseases, e.g. diarrhea and enterocolitis
02/08/2007CA2616941A1 Combination of itriglumide and proton pump inhibitors in the treatment of gastrointestinal and related disorders
02/07/2007EP1749539A2 Preventives or remedies for fatty liver